Acrivon TherapeuticsACRV

13F holders, Q2 2026 (June 30)
46holders +2
6new positions
4sold out
2famous investors
$1.78avg. 13F price*

At the end of Q2 2026, 46 institutions reported holding Acrivon Therapeutics Inc. (ACRV) in their 13F filings, up 2 from Q1 2026. 6 opened new positions and 4 sold out. The largest holders were Ra Capital Management, L.P. ($21.8M), Sands Capital Alternatives, LLC ($4.1M) and Acadian Asset Management LLC ($2.1M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Acrivon Therapeutics Inc.
CUSIP
004890109
Latest filing quarter
Q2 2026

History

Number of 13F holders

020406080 Q1 2024: 48Q1 2024Q2 2024: 55Q2 2024Q3 2024: 55Q3 2024Q4 2024: 63Q4 2024Q1 2025: 63Q1 2025Q2 2025: 53Q2 2025Q3 2025: 48Q3 2025Q4 2025: 48Q4 2025Q1 2026: 44Q1 2026Q2 2026: 46Q2 2026

Total Exit/New Position Q1 2026 → Q2 2026

InstitutionsTotal Value
New Positions6$171K
Exits4$74K

All 13F filers, Q1 2026 → Q2 2026: 5,474,114 shares bought and 307,687 shares sold, net +5,166,427 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 46 holders

Ra Capital Management, L.P. 0.19% Add +46.6% 12,229,396 $21.8M
Sands Capital Alternatives, LLC 0.66% Add +7.8% 2,289,271 $4.1M
Acadian Asset Management LLC 0.00% Add +37.7% 1,165,119 $2.1M
Vanguard Capital Management LLC 0.00% Add +31.9% 952,008 $1.7M
Wellington Management Group LLP 0.00% No change 888,130 $1.6M
Renaissance Technologies 0.00% Add +0.1% 758,863 $1.4M
Two Sigma Investments, LP 0.00% Add +64.7% 641,498 $1.1M
Marshall Wace, LLP 0.00% Reduce -5.1% 531,856 $947K
Bridgeway Capital Management, LLC 0.01% Add +138.4% 378,900 $674K
Geode Capital Management, LLC 0.00% Add +12.2% 265,241 $472K
BlackRock, Inc. 0.00% Add +14.4% 239,112 $426K
Gsa Capital Partners LLP 0.02% Add +7.3% 200,415 $357K
Vanguard Fiduciary Trust Co. 0.00% Add +71.2% 184,128 $328K
XTX Topco Ltd 0.00% Add +166.5% 178,239 $317K
Jane Street Group, LLC 0.00% Reduce -68.9% 74,648 $133K
Northern Trust Corp. 0.00% Add +37.4% 67,202 $120K
State Street Corp. 0.00% No change 67,145 $120K
UBS Group AG 0.00% Add +26.6% 43,850 $78K
Citadel Advisors 0.00% New 41,276 $73K
Dimensional Fund Advisors LP 0.00% Add +59.7% 29,332 $52K
Spark Investment Management LLC 0.10% New 28,300 $50K
Prelude Capital Management, LLC 0.00% No change 24,015 $43K
Bank of America Corp. 0.00% Reduce -0.6% 16,407 $29K
Verdad Advisers, LP 0.03% New 15,054 $27K
Goldman Sachs Group Inc. 0.00% Add +1.2% 14,920 $27K
Squarepoint Ops LLC 0.00% Reduce -51.5% 13,309 $24K
AAF Wealth Management, LLC 0.01% No change 10,678 $19K
HRT Financial LP 0.00% New 10,316 $18K
Marex Group Ltd 0.00% Reduce -50.0% 10,000 $18K
Federated Hermes, Inc. 0.00% No change 7,924 $14K
Barclays PLC 0.00% Add +23.8% 7,354 $13K
FMR LLC 0.00% Reduce -26.2% 6,957 $12K
Morgan Stanley 0.00% Reduce -85.7% 5,233 $9K
Tower Research Capital LLC (TRC) 0.00% Reduce -63.0% 1,677 $3K
Crews Bank & Trust 0.00% New 1,044 $2K
JPMorgan Chase & Co. 0.00% Add +17.7% 751 $1K
Nisa Investment Advisors, LLC 0.00% No change 584 $1K
BNP Paribas Financial Markets 0.00% Reduce -15.3% 537 $956
Redwood Park Advisors LLC 0.00% No change 500 $890
Russell Investments Group, Ltd. 0.00% No change 481 $856
Federation des caisses Desjardins du Quebec 0.00% No change 400 $712
Steward Partners Investment Advisory, LLC 0.00% No change 326 $580
SBI Securities Co., Ltd. 0.00% Add +1.4% 75 $134
Caitong International Asset Management Co., Ltd 0.00% Add +1150.0% 50 $89
Citigroup Inc. 0.00% New 6 $11
Royal Bank of Canada 0.00% Add +20.0% 30 $0

"% of holder's portfolio" is ACRV's weight in each manager's 13F, not the share of Acrivon Therapeutics Inc. the manager owns.